Whether Seattle-based Gen Con and local officials can now reach an understanding on technology could spell the difference between Indianapolis’ hanging onto its most prized convention and potentially losing it to another city.
The Greenfield-based animal health unit has posted more than a half-billion dollars in losses in the past three years, and it will face huge new corporate expenses as it goes its separate way after more than a half-century as part of Eli Lilly and Co.
Local and national reporters clamored for interviews with Mayor Joe Hogsett about Indianapolis' chances, but city officials largely kept quiet while forwarding media to the Indy Chamber and influencing messaging behind the scenes.
Citizens Action Coalition of Indiana says Duke Energy's controversial Edwardsport plant has suffered repeated outages and failed to live up to its promises, costing ratepayers more than $1 billion in unneeded fees.
The drug, launched in 2014, is one of Lilly's fastest-growing medicines, but its fate could hinge on the results of another clinical trial for heart benefits. The Indianapolis-based drugmaker plans to release results later this year.